SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-24-002009
Filing Date
2024-01-24
Accepted
2024-01-24 07:36:44
Documents
15
Period of Report
2024-01-24
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K abt-20240124.htm   iXBRL 8-K 28619
2 EX-99.1 abt-2023q4xexhibitx991.htm EX-99.1 873268
7 abbottlogo.jpg GRAPHIC 7384
  Complete submission text file 0001628280-24-002009.txt   1118050

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT abt-20240124.xsd EX-101.SCH 2255
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT abt-20240124_def.xml EX-101.DEF 15227
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT abt-20240124_lab.xml EX-101.LAB 29504
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT abt-20240124_pre.xml EX-101.PRE 15946
9 EXTRACTED XBRL INSTANCE DOCUMENT abt-20240124_htm.xml XML 4118
Mailing Address 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064-3500
Business Address 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064-3500 2246676100
ABBOTT LABORATORIES (Filer) CIK: 0000001800 (see all company filings)

IRS No.: 360698440 | State of Incorp.: IL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-02189 | Film No.: 24554251
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)